Law firm Holding Redlich has defended national managing partner Ian Robertson against allegations by NSW Labor Party general secretary Kaila Murnain that the lawyer advised her to keep quiet about a $100,000 illegal political donation.
Concerns about duplicative costs in multiple class actions are better addressed by case management decisions aimed at cutting excessive expense, not by limiting the amount lawyers representing group members can spend, the Full Federal Court has said in dismissing an appeal by baby food maker Bellamy’s.
Former Plutus Payroll general manager Joshua Kitson has been sentenced to at least three years in jail for his role in a conspiracy to defraud $105 million from the Australian Taxation Office.
Biotech company Cryosite has agreed to a $1 million settlement for losses resulting from legal advice received in relation to a merger agreement that left the company facing $1.05 million in penalties for engaging in cartel conduct.
Agricultural fund manager Rural Funds Group has briefed a top-tier law firm to bring “unprecedented” legal action against US company Bonitas Research, after the activist short seller accused the group of fraud and sent its share price plummeting.
WorleyParsons may seek to shut down a shareholder class action against it due to an “insuperable obstacle” caused by last minute pleading amendments, the engineering firm told a court at the outset of a 21-day hearing.
The Transport Workers Union has described the Deliveroo business model as “the biggest sham in the modern economy”, as it launched a new sham contracting case against the food delivery service on the back of its victory against Foodora last year.
CFMEU state boss John Setka has lost his court challenge to a vote to expel him from the Australian Labor Party, with the Victorian Supreme Court ruling it did not have the jurisdiction to rule on the case.
Two units of US pharmaceutical giant Pfizer have filed a lawsuit seeking damages from Juno Pharmaceuticals for allegedly infringing the patent for post-operative pain drug Dynastat.
Allianz Australia will refund over $8 million in fees and premiums to customers who were sold worthless cover they were not eligible to make claims under, including teenagers who were sold death cover.
For information on rights and reprints, contact subscriptions@lawyerly.com.au
